Skip to main content

Table 1. Clinical characteristics of the subjects included in this study

From: Lipid metabolic reprogramming mediated by circulating Nrg4 alleviates metabolic dysfunction-associated steatotic liver disease during the early recovery phase after sleeve gastrectomy

  1. Bold values denote statistically significant P values. Control is a group of normal weight, non-operated health subjects. Pre-SG and Pre-SG imply patients with obesity before and the 1 month after sleeve gastrectomy, respectively. Categorical variables are presented as n (%), and continuous variables are presented as mean ± SD
  2. Abbreviations: BMI body mass index, WC waist circumference, WHtR waist-to-height ratio, LSR liver/spleen CT value ratio, ALT alanine aminotransferase, AST aspartate aminotransferase, GGT gamma-glutamyl transferase, TC total cholesterol, TG triglyceride, HDL-c high-density lipoprotein cholesterol, LDL-c low-density lipoprotein cholesterol, HOMA-IR homeostasis model assessment insulin resistance, Nrg4 neuregulin 4